ArticleInternal medicine (Tokyo, Japan)2025

KL-6 as a Tumor Marker of Primary Peritoneal Cancer in Patients with Connective Tissue Diseases.

Takao Nagashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.